PAUL HOPKINS to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications PAUL HOPKINS has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.282
-
Interplay Between Statins, Cav1 (Caveolin-1), and Aldosterone. Hypertension. 2020 09; 76(3):962-967.
Score: 0.102
-
Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects. Circulation. 2015 Nov 10; 132(19):1825-33.
Score: 0.073
-
Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005 Sep; 116(3):682-8.
Score: 0.036
-
Familial hypercholesterolemia--improving treatment and meeting guidelines. Int J Cardiol. 2003 May; 89(1):13-23.
Score: 0.031
-
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia. J Clin Lipidol. 2018 Mar - Apr; 12(2):390-396.e8.
Score: 0.021
-
Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects". Circulation. 2016 Apr 19; 133(16):e606.
Score: 0.019